M&A Deal Summary

SOHM Acquires ABBIE

On September 26, 2023, SOHM acquired information technology company ABBIE from CGA 369

Acquisition Highlights
  • This is SOHM’s 1st transaction in the Information Technology sector.
  • This is SOHM’s 1st transaction in the United States.
  • This is SOHM’s 1st transaction in California.

M&A Deal Summary

Date 2023-09-26
Target ABBIE
Sector Information Technology
Buyer(s) SOHM
Sellers(s) CGA 369
Deal Type Divestiture

Target

ABBIE

San Diego, California, United States
ABBIE is a gene-editing platform that delivers genetic payloads using non-viral vectors. The company uses targeted integration to insert larger DNA sequences (aka, genetic payload), including full genes, into a desired loci of the target cell’s genome. It will edit genes of a large number of cell types at different stages of their life cycles, overcoming the limitations of current cell editing and cell engineering technologies.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

SOHM

Chino Hills, California, United States

Category Company
Sector Life Science
DESCRIPTION

SOHM is a generic pharmaceutical manufacturing and marketing company with a vision of “Globalè Prospèro” that aims to build continuous growth. The company's manufacturing and marketing targets rapidly growing healthcare segments such as nutraceuticals, cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in Chino Hills, California.


DEAL STATS #
Overall 1 of 1
Sector: Information Technology M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2023 M&A 1 of 1

Seller(S) 1

SELLER

CGA 369

Bonita, California, United States

Category Company
Sector Life Science
DESCRIPTION

CGA 369 is a biotech company that caters to the emerging cell engineering space by specializing in protein expression, offering state-of-the-art technologies and innovative solutions to harness the full potential of proteins. The company is driven by a dedicated team of experts combining expertise in molecular biology, genetic engineering, and bioinformatics to unlock the intricate mechanisms of protein synthesis, ensuring precise and optimized expression for a wide range of applications. CGA 369 is based in Bonita, California.


DEAL STATS #
Overall 1 of 1
Sector: Information Technology M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2023 M&A 1 of 1